Related Experiment Video
Updated: Jan 20, 2026

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
Published on: April 7, 2018
Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth
Sarbajeet Nagdas1, Jennifer A Kashatus1, Aldo Nascimento1
1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908, USA.
Abstract:
Mitochondria undergo fission and fusion to maintain homeostasis, and tumors exhibit the dysregulation of mitochondrial dynamics. We recently demonstrated that ectopic HRasG12V promotes mitochondrial fragmentation and tumor growth through Erk phosphorylation of the mitochondrial fission GTPase Dynamin-related protein 1 (Drp1). However, the role of Drp1 in the setting of endogenous oncogenic KRas remains unknown. Here, we show that Drp1 is required for KRas-driven anchorage-independent growth in fibroblasts and patient-derived pancreatic cancer cell lines, and it promotes glycolytic flux, in part through the regulation of hexokinase 2 (HK2). Furthermore, Drp1 deletion imparts a significant survival advantage in a model of KRas-driven pancreatic cancer, and tumors exhibit a strong selective pressure against complete Drp1 deletion. Rare tumors that arise in the absence of Drp1 have restored glycolysis but exhibit defective mitochondrial metabolism. This work demonstrates that Drp1 plays dual roles in KRas-driven tumor growth: supporting both glycolysis and mitochondrial function through independent mechanisms.
Insights
Dynamin-related protein 1 (Drp1) is crucial for KRas-driven tumor growth, supporting both glycolysis and mitochondrial function. Its deletion improves survival in pancreatic cancer models, highlighting its complex role in cancer progression.
Area of Science:
- Mitochondrial dynamics
- Oncogenic signaling pathways
- Cancer metabolism
Background:
- Mitochondria maintain homeostasis through fission and fusion; dysregulation is common in tumors.
- Ectopic HRas promoted mitochondrial fragmentation and tumor growth via Drp1 phosphorylation.
- The role of Drp1 in endogenous KRas-driven cancers was previously unknown.
Purpose of the Study:
- To investigate the role of Dynamin-related protein 1 (Drp1) in KRas-driven tumor growth.
- To determine Drp1's impact on cancer metabolism, specifically glycolysis and mitochondrial function.
- To assess the therapeutic potential of targeting Drp1 in KRas-driven pancreatic cancer.
Main Methods:
- Utilized KRas-driven anchorage-independent growth assays in fibroblasts and pancreatic cancer cell lines.
- Assessed the effect of Drp1 deletion on tumor growth and survival in a KRas-driven pancreatic cancer model.
- Investigated Drp1's regulation of glycolytic flux and hexokinase 2 (HK2) expression.
- Analyzed metabolic profiles of tumors with and without Drp1 deletion.
Main Results:
- Drp1 is essential for KRas-driven anchorage-independent growth and promotes glycolytic flux partly via HK2 regulation.
- Drp1 deletion significantly enhances survival in a KRas-driven pancreatic cancer model, with strong selective pressure against its complete absence.
- Tumors lacking Drp1 exhibit restored glycolysis but impaired mitochondrial metabolism, indicating dual roles.
- Drp1 supports both glycolysis and mitochondrial function through distinct mechanisms in KRas-driven tumors.
Conclusions:
- Drp1 plays critical, dual roles in KRas-driven tumor progression by supporting both glycolysis and mitochondrial function.
- Targeting Drp1 presents a potential therapeutic strategy for KRas-driven pancreatic cancers.
- Understanding Drp1's complex regulation of cancer metabolism is key for developing effective treatments.
More Related Videos
Related Concept Videos
What is Metabolism?
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Population Growth

